石杉鹼甲

[ 藥草來源 ] Huperzia serrata (Thunb.) Trev.
[規格] 98％石杉鹼甲
[檢測方法] HPLC
[分子式和分子量] C15H18N2O：242.32
[藥理作用] 
它可以治療重症肌無力，老年性癡呆和青少年學習障礙。
關於石杉鹼甲
Huperzine A (HUP-er-zeen) is a potent chemical derived from a particular type of club moss ( Huperzia serrata [Thumb] Trev.).石杉鹼甲（HUP-er-zeen）是一種有效的化學物質，衍生自一種特殊類型的俱樂部苔蘚（石杉石杉）。 Like caffeine and cocaine, huperzine A is a medicinally active, plant-derived chemical that belongs to the class known as alkaloids.像咖啡因和可卡因一樣，石杉鹼甲是一種具有藥理活性的植物源性化學物質，屬於生物鹼類。 It was first isolated in 1948 by Chinese scientists.1 This substance is really more a drug than an herb, but it is sold over the counter as a dietary supplement for memory loss and mental impairment.它於XNUMX年由中國科學家首次分離出來。XNUMX這種物質的確比藥草更像是一種藥物，但它作為非處方藥出售，可以作為記憶力減退和精神障礙的飲食補充。
Huperzine is a chemical that comes from a Chinese herb called Huperzia serrata.石杉鹼是來自一種叫做石杉石杉的中草藥的化學物質。 Huperzine, a moss extract, has been used for many centuries in traditional Chinese medicine and is used for Alzheimer's disease.石杉鹼是一種苔蘚提取物，已經在許多傳統中藥中使用了多個世紀，並被用於治療阿爾茨海默氏病。
Huperzine A acts like a cholinesterase inhibitor.石杉鹼甲的作用類似於膽鹼酯酶抑製劑。 It increases the amount of acetylcholine in very much the same way as the FDA (Food and Drug Administration) approved medications such as Aricept.它以與FDA（食品和藥物管理局）批准的藥物（例如Aricept）幾乎相同的方式增加乙酰膽鹼的量。
There have been a number of small studies into the effectiveness of Huperzine which have found that it is more effective than a placebo.對石杉鹼的有效性進行了許多小型研究，發現石杉鹼比安慰劑更有效。 Improvements have been seen in cognition, memory and in the behavior of people with Alzheimer's disease.在阿爾茨海默氏病患者的認知，記憶和行為方面已見改善。 One of the main problems is the studies have only been small ones and there is a need for further investigation and larger scale studies into its effectiveness for mild and moderate Alzheimer's disease.主要問題之一是該研究還很小，需要進一步研究和大規模研究其對輕度和中度阿爾茨海默氏病的有效性。
不建議結合石杉鹼和FDA批准的用於阿爾茨海默氏症的膽鹼酯酶藥物，因為目前尚無關於安全性，功效或副作用的研究。
It is recommended that the FDA approved medication be used rather than Huperzine A because first there is evidence and research to support their use.建議使用FDA批准的藥物而不是石杉鹼甲，因為首先有證據和研究支持其使用。 Secondly, the dosage of FDA approved medications are consistent, a problem with some alternative treatments for Alzheimer's disease.其次，FDA批准的藥物劑量是一致的，這是阿爾茨海默氏病某些替代療法的問題。